Neoadjuvant treatment strategies for hepatocellular carcinoma  

作　　者：Lei Xu Lin Chen Wei Zhang 

机构地区：[1]Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,Hubei Province,China

出　　处：《World Journal of Gastrointestinal Surgery》2021年第12期1550-1566,共17页世界胃肠外科杂志（英文版）（电子版）

基　　金：National Natural Science Foundation of China,No.81860117.

摘　　要：The incidence of hepatocellular carcinoma(HCC)remains high globally.Surgical treatment is the best treatment for improving the prognosis of patients with HCC.Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC.The liver transplantation rate and resectability rate have increased for neoadjuvant therapy.Neoadjuvant therapy is effective in different stages of HCC.In this review,we summarized the definition,methods,effects,indications and contraindications of neoadjuvant therapy in HCC,which have significance for guiding treatment.

关 键 词：Hepatocellular carcinoma Neoadjuvant therapy PROGNOSIS INDICATIONS CONTRAINDICATIONS 

分 类 号：R735.7[医药卫生—肿瘤]